Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems

The 2008–2012 French Alzheimer Plan: Description of the National Alzheimer Information System

(2018) Franck Le Duff et al.   JOURNAL OF ALZHEIMERS DISEASE

Long-term use of antipsychotics in community-dwelling dementia patients

(2017) Quentin Boucherie et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

(2017) Julien Bezin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies

(2016) Aurore Palmaro et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence

(2015) Hayley E. Jones et al.   ADDICTION

Bayesian estimation of a cancer population by capture-recapture with individual capture heterogeneity and small sample

(2015) Laurent Bailly et al.   BMC Medical Research Methodology

Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

(2013) L. E. Hebert et al.   NEUROLOGY

Fine-grained record integration and linkage tool

(2008) Pawel Jurczyk et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY